Testing a new two-sided heart pump for severe heart failure
Part of Heart & circulation clinical trials.
This trial is testing a new mechanical heart pump designed to support both sides of the heart. You may be eligible if you have advanced, severe heart failure that is not getting better with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have severe heart failure that affects both sides of your heart, and you need medicine to keep your blood pressure up or have very low blood flow from your heart.
- Your left heart is very weak (ejection fraction 30% or less) or pressure in your lung blood vessels is high (wedge pressure over 15 mmHg).
- You have at least two signs that your right heart is also weak, such as low right heart output, small valve motion, or high pressure in your veins.
- You are willing to take blood thinners and do not have a medical condition that would make surgery too risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump device (DuoCor 2) that supports both sides of the heart for people with severe heart failure that has not improved with other treatments. The goal is to see if the device is safe and helps improve heart function.
This trial is studying a non-surgical (conservative) treatment approach for people being considered for a left ventricular assist device (LVAD). It may help some patients who are too sick or unable to tolerate standard heart failure medicines, but it will only match people with specific heart function and health-test results.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Hear when a new Advanced Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.